Validated sites related to brain health and general information for older adults and caregivers, from external sources and from Dana publications.
The Dana Alliance for Brain Initiatives' Staying Sharp program includes live public forums, printed and printable resources, and videos.
Reviews by eminent neuroscientists of specific areas of research, including normal function, disease, and new technologies.
BrainWeb provides information and links to validated sites about brain diseases and disorders from external sources and from Dana publications.
To tease out what distinguishes the aging brain from the diseased brain, researchers are collecting reams of data, from types of neurons in the brain to changes in people’s behavior.
New research suggests that ‘eudaimonic well-being’ might dampen harmful inflammation and delay Alzheimer’s
We’ve heard a lot lately about brain-to-machine communication, and now there are first steps toward brain-to-brain communication. How do we prevent news of incremental discoveries from transporting our imaginations way too far?
People who studied music as children—and stopped when they were children—performed better at some hearing tasks decades later than those who never studied music.
Two major initiatives aim to find anotomical or physiological changes that could lead to earlier detection and potential treatment.
Many recent studies have demonstrated that sleep benefits all aspects of neural plasticity. Currently under investigation are the underlying cellular mechanisms, which should explain why these benefits can only be obtained when the brain is off-line. One of our series of Reports on Progress.
Even without a disease such as Alzheimer’s, the aging brain does show signs of wear. Researchers look to the molecular level to see if they can slow the ‘normal’ progress.
A series of recent studies has found that by directing attention systematically, repeatedly, and over time, people who meditate appear to effect changes in brain function and connectivity comparable to those associated with fMRI neurofeedback and consistent with observed behavioral benefits. Some investigators describe structural changes as well.
Are the drugs ineffective? Or is there something about large trials that obscures their effectiveness?